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Abstract 30 
Tropical theileriosis is a tick-borne haemoparasitic disease of cattle caused by the protozoan 31 
parasite Theileria annulata. Globally, the economic impact of the disease is immense and 32 
enhanced control measures would improve livestock production in endemic regions. 33 
Immunisation with a live attenuated vaccine is an effective and widely used control method, 34 
however, the repeated use of live vaccines may have an impact on the field parasite population at 35 
a genetic level. Additionally, there has been an increasing number of reports of vaccine 36 
breakthrough cases in recent years. Thus, the present study was designed to evaluate the genetic 37 
composition of a parasite population over a disease season in a locality where live cell line 38 
vaccination is practised. A diverse range of parasite genotypes was identified and every T. 39 
annulata positive cattle blood sample harboured multiple parasite genotypes. An alteration in the 40 
major genotype and an increasing multiplicity of infection in individual animals was observed 41 
over the course of the disease season. Vaccination status was found not to effect within-host 42 
multiplicity of infection, while a significantly higher number of genotypes was detected in 43 
grazed cattle compared to non-grazed ones. A degree of genetic isolation was evident between 44 
parasite populations on a micro-geographic scale, which has not been reported previously for T. 45 
annulata. Analysis of parasite genotypes in vaccinated animals suggested only a transient effect 46 
of the vaccine genotype on the genetic diversity of the T. annulata population. The vaccine 47 
genotype was not detected among clones of two vaccine ‘breakthrough’ isolates and there is no 48 
suggestion that it was responsible for disease. The obtained data indicated that in the system 49 
studied there is no apparent risk of introducing the vaccine genotype into the population with 50 
only a transient effect on the genetic diversity of the parasite population during the disease 51 
season. 52 
Key words: Theileria annulata, vaccine, infection dynamics, genetic diversity  53 
1. Introduction 54 
Tropical theileriosis is caused by the protozoan parasite Theileria annulata and is transmitted by 55 
several species of Ixodid ticks of the genus Hyalomma. It is an economically important bovine 56 
disease, which is widespread between longitudes 30◦W-150◦E and latitudes 15◦N-60◦N. The 57 
parasite has a cattle-tick-cattle life cycle which, in the bovine host, involves two major asexual 58 
replicative phases. The first of these takes place within leukocytes and the second within 59 
erythrocytes. After piroplasm-containing erythrocytes are ingested by a feeding tick, a sexual 60 
cycle occurs within the tick (Schein and Friedhoff, 1978). Male and female gametes are formed 61 
which fuse to form zygotes, which in turn differentiate into kinetes that migrate to the salivary 62 
glands, ultimately generating bovine-infective sporozoites (Gauer, 1995; Schein and Friedhoff, 63 
1978). Recent population genetic studies have provided further indirect evidence for the 64 
occurrence of a sexual phase in the parasite life cycle and these indicate that random mating is a 65 
feature of field populations of T. annulata (Al-Hamidhi et al., 2015; Gomes et al., 2016; Weir et 66 
al., 2007). Sexual recombination, together with a high transmission rate, is understood to play a 67 
significant role in generating T. annulata genetic diversity in different regions (Katzer et al., 68 
2006; Pumpaibool et al., 2009). 69 
Currently, prevention and control measures against tropical theileriosis comprise: (i) control of 70 
the tick vector, (ii) treatment of infected animals, (iii) use of disease-resistant breeds of cattle 71 
and (iv) vaccination with attenuated cell lines. Each of these methods, however, suffers from 72 
various drawbacks. Tick control using acaricides is unsustainable due to emerging resistance and 73 
food safety concerns (Graf et al., 2004; Khater et al., 2016). The drugs used for treatment, 74 
parvaquone and buparvaquone, have been in use since the 1980s and an increased rate of 75 
treatment failures has been observed in recent years, with buparvaquone-resistant parasites 76 
detected in Turkey (Hacilarlioglu, 2013), Tunisia (Mhadhbi et al., 2010) and Iran (Sharifiyazdi 77 
et al., 2012). A small number of indigenous cattle breeds from disease-endemic regions has been 78 
shown to possess innate disease-resistance, such as Sawihal and Kenana cattle in India (Glass et 79 
al., 2005). However, the ability of other breeds to resist or tolerate tropical theileriosis is largely 80 
unknown and a substantial amount of work is required to gauge the importance of breed 81 
resistance in combatting tropical theileriosis on a broad scale. Vaccinating cattle using 82 
attenuated T. annulata cell line vaccines has been shown to be an effective method for 83 
controlling disease (Darghouth et al., 1999; Seitzer and Ahmed, 2008) and this has been adopted 84 
in a number of countries, including Turkey. Attenuation of virulence of schizont-infected cell 85 
line cultures via long term in vitro passage has been associated with a reduction in the number of 86 
genotypes contained within the cell line (Darghouth et al., 1996; Pipano and Shkap, 2000). For 87 
example, the vaccine used in Turkey, based on the Pendik cell line, may comprise only a single 88 
haploid T. annulata genotype (Weir et al., 2011). The use of attenuated live cell line vaccines 89 
has been shown to provide solid immunity against homologous challenge and partial cross-90 
protection against heterologous challenge (Darghouth et al., 1996; Gill et al., 1980; Hashemi-91 
Fesharki, 1988). The protection provided by vaccination is not associated with the induction of 92 
sterile immunity and it may be hypothesised that vaccinating cattle exposed to field challenge 93 
with a single parasite genotype may perturb the parasite population harboured by these animals. 94 
It may be further hypothesised that vaccination could result in the positive selection of genotypes 95 
which are poorly protected against, thereby altering the genetic composition of the local parasite 96 
population. 97 
The long-term effectiveness of current vaccines in endemic regions and the influence of 98 
vaccination on field parasite populations remain poorly understood. Clinical theileriosis has been 99 
observed in vaccinated cattle during the disease season in Turkey (Aysul et al., 2008). Recent 100 
field reports indicate an increasing number of ‘breakthrough’ cases in vaccinated animals 101 
(unpublished observation) and investigating the genetic basis of this phenomenon is now 102 
essential. Previous genetic analysis of T. annulata field populations using a panel of molecular 103 
markers has revealed a high level of genotypic diversity with large numbers of distinct parasite 104 
genotypes detected within limited geographical areas (Al-Hamidhi et al., 2015; Gomes et al., 105 
2016; Weir et al., 2007; Yin et al., 2018). Furthermore, a previous study has indicated that the 106 
level of multiplicity of is influenced by vaccination status and that cell line vaccinated cattle tend 107 
to be infected with more genotypes than unvaccinated cattle (Weir et al., 2011). Besides the 108 
existence of distinct genotypes in field populations of the parasite, the influence of vaccination 109 
on field parasite population dynamics remain unknown. In the present study, we have 110 
investigated the dynamics of parasite infection over the course of a disease season following 111 
vaccination with a commercial cell line vaccine, measuring parasite genotypic diversity in the 112 
cattle population both pre- and post-immunisation together with investigating the genetic basis 113 
of ‘breakthrough’ cases in vaccinated animals. 114 
2. Materials and methods 115 
2.1. Parasite material 116 
The study was conducted at seven farms, with a history of tropical theileriosis, located within 117 
four different villages (one farm from Seferler, three from Centrum, one from Sarikoy and two 118 
from Kabalar) in the Akçaova district of Aydın province in Western Turkey where tropical 119 
theileriosis is endemic. A map illustrating the geographical location of sampling sites is shown 120 
in Supplementary Fig S1. A total of 143 cattle from Seferler (n = 13), Centrum (n = 55), 121 
Sarıkoy (n = 20) and Kabalar (n = 55) were screened for T. annulata between April and 122 
September 2013. Both calves and adult cattle vaccinated with the attenuated schizont vaccine 123 
TeylovacTM (Vetal, Turkey) were sampled pre- and post-immunisation. Blood samples were 124 
collected in EDTA tubes immediately prior to and 45 days after vaccination and subsequently at 125 
30-day intervals during the disease season (Fig 1). Cattle consisted of mainly dairy types 126 
(Holstein and Brown Swiss) and Simmental together with a small number of cross-bred cattle. 127 
Details of the animals sampled in this study are summarised in Supplementary Table S1, 128 
including location, sex, age, breed and grazing history. 129 
In order to evaluate the genetic diversity of parasites in non-vaccinated co-grazed carrier cattle, 130 
samples from 44 non-vaccinated cattle in Sarikoy village were also collected at Day 105 131 
following vaccination (Supplementary Table S1). In addition to blood samples taken for 132 
parasite detection and genotyping, peripheral blood mononuclear (PBM) cells isolated from 133 
cattle showing signs of clinical disease were collected in heparinised tubes during the disease 134 
season and macroschizont-infected cell lines were established in vitro as previously described 135 
(Brown, 1987). In vitro cultivated isolates and the commercially available Turkish vaccine line 136 
TEYLOVACTM (Vetal, Turkey), derived from the Pendik cell line (Boulter and Hall, 1999), 137 
were cloned by limiting dilution of cell lines using the method described by Shiels et al., (1986). 138 
2.2. DNA preparation and screening for the presence of T. annulata  139 
EDTA blood samples collected from animals were divided into aliquots and stored at -20 ºC. 140 
Frozen blood samples were thawed and 300 µl of whole blood was used to extract DNA using 141 
the Promega Wizard genomic DNA extraction kit (Madison, WI, USA) following the 142 
manufacturer’s instructions. Extracted DNA was resuspended in 100 µl rehydration buffer and 143 
stored at -20 °C until used. All DNA samples were initially screened for the presence of 144 
T. annulata using the Cytob1 PCR protocol as previously described (Bilgic et al., 2010) and 145 
parasite-positive samples were then subjected to genotyping. To allow analysis of 146 
‘breakthrough’ isolates, DNA was prepared from cloned cell line cultures having 2 x 106 147 
cells/ml using the same methodology. 148 
2.3. Mini- and micro-satellite genotyping 149 
A total of 23 polymorphic mini- and micro-satellite markers were used to genotype parasite 150 
isolates, as described previously (Bilgic et al., 2017; Weir et al., 2007). These included 14 151 
microsatellites (Tmsc 1, 31, 33, 37, 45, 48, 68, 75, 77, 86 and TS 5, 9, 12, 16) and nine 152 
minisatellites (MSC 8, 19, 14 and TS 6, 8, 15, 20, 25, 31) distributed across each of the four 153 
chromosomes of the T. annulata genome. The reagents required and thermocycler conditions 154 
selected for PCR amplification have been previously described (Bilgic et al., 2017; Weir et al., 155 
2007), except in the present study the PCR primers were not fluorescently tagged. 156 
2.4. High-resolution separation of amplified alleles using ‘Spreadex’ gels 157 
High-resolution Spreadex gels (Elchrom ScientificTM) were used to determine the size of 158 
amplicons representing the alleles of each mini- and micro-satellite marker. Under optimal 159 
conditions, these gels provide a resolution of up to 3 bp. Following electrophoresis, gels were 160 
stained in 30 mM Tris–acetate-EDTA (TAE) buffer containing 0.4 µg/ml of Gelred (Biotium, 161 
USA) for 40 min and then destained in distilled water for 30 min. Gels were then viewed under 162 
UV light (254 nm) and photographed. VisionWorksLS (Versiyon 6.8) software (UVP EC3 Bio-163 
Imaging system, USA) was used to determine allele size by direct comparison with the M3 164 
marker (Elchrom Scientific), which contains over 50 DNA fragments between the sizes of 75 bp 165 
and 622 bp. The M3 marker has been specifically designed for the accurate sizing of micro- and 166 
mini-satellite alleles that may differ in size by as little as three base pairs. 167 
2.5. Data analysis  168 
Multi-locus genotypes (MLG) were defined for T. annulata positive samples collected from pre- 169 
and post-vaccinated animals, in vitro cultivated field isolates of T. annulata and clones derived 170 
from the Turkish vaccine line (TeylovacTM) based on the sizes of the alleles detected at each 171 
locus. In samples where more than one allele was amplified at a particular locus, the 172 
predominant allele was identified on the basis of the intensity of Gelred staining. Alleles were 173 
binned using a model-based approach implemented in Tandem2 (Matschiner and Salzburger, 174 
2009). For the majority of micro-satellite markers (13 of 14), the Tandem2-predicted period size 175 
corresponded to the identified period size in the reference T. annulata genome (Pain et al., 2005) 176 
(Supplementary Table S2). For seven of the nine mini-satellites markers (TS6, TS8, TS15, 177 
TS20, TS25, MSC8 and MSC14), for which allelic polymorphism may not be explained by a 178 
simple step-wise mutation model, a shorter period size was chosen (Supplementary Table S2). 179 
A genetic difference matrix was constructed and principle co-ordinate analysis (PCoA) was 180 
undertaken using GenAlEx v.6.5 (Peakall and Smouse, 2012). A second matrix was constructed 181 
which represented both the major and minor alleles present at each locus, thus providing a 182 
comprehensive genetic ‘finger-print’ representing the mixture of genotypes within each isolate. 183 
Multiplicity of infection (MOI) was estimated for each isolate by calculating the average number 184 
of alleles present per locus. To test for differences in vaccine-allele frequency between groups of 185 
animals, One-way ANOVA with Tukey HSD, Scheffé and Bonferroni and Holm post hoc tests 186 
of significance were utilised. To test for differences in proportions of infected/uninfected 187 
animals per group, Fisher’s Exact test was used. To test for differences in the MOI between 188 
vaccinated and unvaccinated animals, Student’s T test was used. The probability of discovering 189 
the vaccine genotype among clones was calculated using a cumulative Binomial function. 190 
2.6. Ethical statement 191 
This study was approved by Adnan Menderes University Animal Experiment Ethics Committee 192 
dated 27/03/2015 in accordance with decision number B.30.2.ADÜ.0.00.00.00/050.03/2015/029. 193 
3. Results 194 
3.1. Screening for the presence of T. annulata 195 
A sub-set of the cattle present at each of the premises was sampled before and after vaccination. 196 
The number of animals that could be sampled on each premises varied at different time-points 197 
during the disease season due to local management factors (Table 1), but where possible, the 198 
same animals were sampled on subsequent visits. A breakdown of the sampling schedule for 199 
individual animals over each time-point is provided in Supplementary Table S3. For 200 
comparative purposes, a number of non-vaccinated cattle, which were co-grazed with vaccinated 201 
cattle, were also sampled during the disease season. At the beginning of the disease season, 202 
immediately prior to vaccination (Day 0), only four of 143 animals (2.8 %) were found to be 203 
infected with T. annulata. Twenty of the cattle in the study cohort had been vaccinated the 204 
previous year and except three animals (HO13, HO20 and ME05) that were parasite positive at 205 
the pre-vaccination time-point, all remaining cattle were negative. Over the course of the disease 206 
season, the parasite was detected in a large proportion of samples (Table 1) in both vaccinated 207 
and non-vaccinated animals. Sixty-five T. annulata positive samples were identified over the 208 
course of the study and these were collected from a total of 33 different animals. Of the four 209 
cattle that were positive at Day 0 (pre-vaccination) (Table 1), three of these (SC02, HO13 and 210 
ME05) remained positive throughout the disease season. Animal HO20 also remained positive 211 
throughout the disease season, except at Day 75. The remaining positives comprised the samples 212 
collected from a total of 29 cattle over a number of time-points. T. annulata was also detected in 213 
29 of 44 non-vaccinated cattle (Table 1) at Day 105, towards the end of the season. These cattle 214 
were located on a single farm (SC) and were co-grazed with vaccinated cattle. 215 
3.2. Population diversity and geographical sub-structuring 216 
Multi-locus genotypes were established for every T. annulata positive sample, and these are 217 
detailed in Supplementary Table S4. Principal co-ordinate analysis (PCoA) of multi-locus 218 
genotypes detected on six farms in Akçaova district demonstrated that a diverse range of parasite 219 
genotypes could be identified in the vaccinated cattle (Fig 2). The two axes account for 32 % of 220 
the variation in genetic diversity across the dataset. While the populations of six different farms 221 
are not entirely distinct, samples from the Sarikoy, Centrum and Kabalar study sites formed 222 
three distinguishable clusters, suggesting a degree of genetic isolation between T. annulata 223 
genotypes at a local level. The samples from Seferler are positioned within the Kabalar cluster. 224 
In order to investigate genetic diversity among isolates collected from individual cattle on a 225 
temporal basis, the genotypes from the three positive animals at all five time-points were 226 
identified and their centroids defined (Fig 2). This clearly illustrates that there is a turnover of 227 
major genotype present in each individual animal. Compared to the MLGs detected in animals 228 
SC02 and ME05, those detected in HO13 showed lower diversity, illustrated by tighter 229 
clustering on the PCoA, with three of the MLGs being highly similar to one another. 230 
3.3 Effect of grazing on genotyping 231 
Across the study sites, the sampled animals were kept under similar management conditions 232 
(Supplementary Table S1). A small proportion of cattle were not grazed, and a number of these 233 
were sampled at Day 45 and Day 75 following vaccination for comparison with grazed animals. 234 
Over Day 45 and Day 75, a total of 47 T. annulata positive cattle were identified, 25 of which 235 
were grazed and 22 were not (Table 1). MLGs could be established from the majority of 236 
samples from grazed cattle but only a small number of non-grazed cattle. Strikingly, on Day 75, 237 
nine of ten infected grazed cattle could be genotyped, whereas only one of ten non-grazed 238 
infected animals generated a MLG. This is a statistically significant finding (Fisher’s Exact Test, 239 
P < 0.001) and may be explained by a low-level parasite burden in non-grazed animals. 240 
3.4. Multiplicity of infection 241 
Multiple alleles at one or more loci were detected in every T. annulata positive field sample, 242 
indicating co-infection with two or more parasite genotypes. On average 1.7 alleles per locus 243 
were detected at the beginning of the disease season in grazing animals, immediately prior to 244 
vaccination (Fig 3A). This had dropped to 1.3 alleles per locus by Day 45, rising to 2.5 at Day 245 
105. At Day 105, a cohort of non-vaccinated grazed cattle were sampled and found to have 2.7 246 
alleles per locus, which was not significantly different from the vaccinated cohort (Student’s T 247 
Test - two-tailed, P = 0.30). To investigate whether a rising level of MOI could be observed in 248 
individual animals at different farms, three cattle were longitudinally sampled. A rising MOI 249 
over the disease season was noted for each animal (Fig 3B). Animal H013 maintained a higher 250 
number of parasite genotypes (>2 alleles per locus) than the other two grazing cattle throughout 251 
the disease season. 252 
3.5. Cloning and genotyping of the vaccine strain 253 
Cattle were vaccinated with a commercial cell line vaccine, Teylovac, early in the disease season 254 
(Day 0). To investigate genotypic diversity in the vaccine cell line, it was cloned by limiting 255 
dilution and 58 clones were genotyped at 21 loci; the results are presented in Supplementary 256 
Table S5. A very low proportion of markers failed to yield a product. Identical parasite 257 
genotypes were detected in each clone across 20 loci. Surprisingly, at MSC8, two alleles were 258 
detected; an allele of 426 bp was detected in 49 clones, while one of 421 bp was detected in the 259 
remaining nine. This corresponded to a heterozygosity of 0.262 for the marker MSC8 and an 260 
overall very low heterozygosity of 0.0114. 261 
3.6. Comparison of field samples and vaccine strain 262 
To determine if the Teylovac genotype could be detected in animals post-vaccination, the sets of 263 
predominant multi-locus genotypes for each time-point were screened for its presence, however 264 
the Teylovac genotype was not detected in any individual. In order to determine whether the 265 
Teylovac genotype represented a minor component within the complex mixture of genotypes in 266 
field isolates, the entire dataset was analysed to determine the frequency of Teylovac-type alleles 267 
on a marker-by-marker basis at each time-point post-vaccination. The results are illustrated in 268 
Fig 4A. A relatively high frequency of vaccine-type alleles was detected in vaccinated animals 269 
at Day 45 post-vaccination, although this was not maintained throughout the rest of the season. 270 
A statistically significant difference in vaccine-allele frequency was detected among the various 271 
groups tested (One-way ANOVA, P < 0.001). Post hoc analysis using Tukey HSD, Scheffé and 272 
Bonferroni and Holm tests indicate that the Day 45 group has a higher vaccine-allele frequency 273 
than both the Day 75 group (P < 0.01) and the non-vaccinated cohort (P < 0.01). This suggests 274 
that the vaccine genotype has just a passing effect on the genetic diversity of the cattle-275 
associated T. annulata population during the disease season. To investigate this further, the 276 
frequency of vaccine alleles at each marker at the Day 45 time-point was compared to that of the 277 
non-vaccinated animals (Fig 4B). While the Day 45 group had a higher frequency at eight of the 278 
markers in the present study, at many loci the vaccine-type allele could not be detected in either 279 
group. This indicates that the enrichment for Teylovac alleles in the population is both subtle and 280 
transient. 281 
3.7. Genotyping of ‘breakthrough’ isolates 282 
In order to analyse vaccine ‘breakthroughs’ for the presence of the Teylovac genotype, two 283 
exemplar vaccinated animals showing clinical signs were analysed in depth, one from farm HO 284 
and one from farm SC. The diagnosis of tropical theileriosis was confirmed in both these 285 
animals clinically, microscopically and by PCR. The HO breakthrough strain was isolated from 286 
a cow showing a variety of clinical signs including pyrexia (41 ºC), lymphadenopathy and a drop 287 
in milk production at Day 75 post-vaccination. The SC breakthrough strain was isolated at Day 288 
135 post-vaccination from a calf with more severe clinical signs. Forty clones were generated 289 
from the HO isolate and 16 from the SC isolate and in neither case was the vaccine genotype 290 
detected (Table 2). From the HO isolate, up to three alleles were identified at a single locus and 291 
five different genotypes were detected overall. In contrast, the SC clones were unique with up to 292 
six alleles detected at a single locus. Thus, the SC isolate showed much greater heterozygosity 293 
than the HO isolate. With this appreciable number of clones generated, the study was sufficiently 294 
powered to detect the Teylovac genotype if present as a 25 % component in a mixed genotype 295 
infection. For these two clinical cases, the data indicates that the vaccine genotype does not form 296 
a major component of the within-animal parasite population in a breakthrough infection and it is 297 
therefore is unlikely to be associated with the clinical signs displayed. 298 
4. Discussion 299 
Tropical theileriosis hampers livestock production in endemic countries and has a particularly 300 
strong impact on the most productive cattle breeds. It is essential to investigate and quantify the 301 
dynamics of parasite infections to allow informed development and deployment of novel control 302 
strategies (Auburn et al., 2012; Weir et al., 2007). Among the control measures available to limit 303 
losses incurred by disease, live attenuated vaccination remains an important, effective and 304 
widely used method in endemic countries (Darghouth et al., 1996; Shkap et al., 2007). However, 305 
vaccination may potentially shape genetic diversity in T. annulata field populations (Weir et al., 306 
2011) with repeated vaccination exerting a selective pressure on the parasite population 307 
(Darghouth et al., 1996). Thus, diversity within a local parasite population needs to be 308 
investigated over a disease season to help evaluate the sustainability of live vaccine-based 309 
control strategies. 310 
Characterising the parasite genotypes co-infecting a single host is a useful investigative approach 311 
which can help to improve understanding of the dynamics of infections, the effects of 312 
transmission intensity and the genetic diversity of the local parasite population (Ross et al., 313 
2012). In the present study, the dynamics of parasite infection over the course of a disease 314 
season following vaccination with a commercial cell line vaccine, Teylovac, was investigated in 315 
samples collected during the pre- and post-immunisation periods. Each T. annulata positive field 316 
sample was found to harbour multiple alleles at one or more loci, indicating co-infection with 317 
two or more parasite genotypes. At the beginning of the disease season (Day 0), an average of 318 
1.7 alleles per locus were detected, indicating the existence of co-infections in sampled animals 319 
just prior to vaccination. These animals had been vaccinated during previous years and, as 320 
anticipated, this result provides clear evidence that vaccination does not induce sterile immunity. 321 
Following vaccination, the number of alleles detected at each locus rose to 2.4 at the end of the 322 
disease season (Day 135) and this clearly indicates an increase in the number of co-infecting 323 
parasites per animal over time (Fig 3A). The necessity of discovering whether the MOI in 324 
vaccinated animals relates to pre- or post-vaccinal challenge has been indicated (Weir et al., 325 
2011). It is evident from the present study that the high MOI in vaccinated animals was 326 
primarily related to post-vaccinal challenge. Such a high level of multiple infection events is 327 
expected in areas where the disease is endemically present and multiple parasite genotypes are 328 
circulating (Weir et al., 2011). The existence of multiple genotypes and the level of MOI in field 329 
samples may be associated with factors including pressure of tick infestations and the prevalence 330 
of T. annulata in the tick population (Elisa et al., 2015; Oura et al., 2005). 331 
In the present study, the most abundant genotype detected in sampled animals changed over the 332 
course of the disease season and variation was observed in the level of MOI. The most 333 
parsimonious explanation for these results is that cattle are continuously challenged with a range 334 
of parasite genotypes from which cell line vaccination does not prevent from establishing a 335 
detectable infection. When analysed over the five time-points, some individuals harboured 336 
somewhat similar parasite genotypes, while in others a diverse range of genotypes was evident. 337 
For example, in animal HO13, despite the presence of a higher MOI (Fig 3B), less genetic 338 
diversity was observed compared to MLGs detected in animals SC02 and ME05 (Fig 2). Factors 339 
such as repeated vaccination using the same cell line may be predicted to result in an alteration 340 
in the T. annulata field population (Darghouth et al., 1996; Weir et al., 2011). For example, it 341 
may be hypothesised that positive selection of particular genotypes, either ‘escape’ genotypes or 342 
the vaccine strain itself, may occur and these may infect ticks. Such selection, followed by 343 
recombination events in ticks may generate multiple but closely-related genotypes. In T. parva, 344 
the sub-structuring of parasite populations at a micro-geographical scale has been interpreted as 345 
being the result of selection of closely-related genotypes (Asiimwe et al., 2013) rather than a 346 
cross-fertilisation among diverse parasite genotypes. On a broad geographical scale, the 347 
variation in the MOI and genetic diversity among individual animals representing different 348 
sampling sites may be related to differential distribution of tick species or varying degrees of 349 
transmission intensities (Weir et al., 2011). However, the present study effectively controlled for 350 
these factors by sampling in a single locality. 351 
Repeated challenge by ticks carrying distinct parasite genotypes may be inferred from the PCoA 352 
of multi-locus genotypes detected in animals SC02 and ME05 (Fig 2). The disease season in 353 
Turkey is between May and September, with a peak in clinical cases occurring in mid-summer 354 
which coincides with an increase of adult Hyalomma tick burdens (Sayin et al., 2003). Only a 355 
single round of mating per year is expected to occur in the Hyalomma population. So, one may 356 
expect to see a major peak of cases in the disease season due to completion of the life cycle in a 357 
limited time period. However, during this study we observed adult Hyalomma ticks feeding on 358 
cattle at each sampling time-point and farmers reported the existence of feeding ticks prior to the 359 
disease season. This indicated the existence of differences in activation times of infected ticks 360 
within the locality studied. 361 
High genotypic diversity and co-infection with multiple genotypes is a common feature of 362 
bovine T. annulata infection (Al-Hamidhi et al., 2015; Ben Miled et al., 1994; Weir et al., 2007; 363 
Weir et al., 2011; Yin et al., 2018). In the present study, a diverse range of parasite genotypes 364 
was identified in the vaccinated cattle over a disease season (Fig 2) and non-vaccinated animals 365 
at Day 105 of the sampling period (Fig 3B). Geographical sub-structuring at a large 366 
geographical scale has been documented between T. annulata populations in Tunisia, Turkey, 367 
Portugal and Oman (Al-Hamidhi et al., 2015; Gomes et al., 2016; Weir et al., 2007), but this has 368 
not been clearly demonstrated at the within-country level. In this study, a diverse range of 369 
parasite genotypes was observed in vaccinated animals on six different farms located within the 370 
same district (Fig 2). PCoA of multi-locus genotypes showed that some farms (Sarikoy, 371 
Centrum and Kabalar) separated into clusters, to an extent, suggesting a degree of genetic 372 
isolation. This may be partly explained by re-sampling the same cattle and thus identifying the 373 
same or closely related genotypes, resulting in a perceived degree of genetic isolation at a local 374 
level. In T. parva, similar sub-structuring was observed in a single farm in Uganda with multiple 375 
divergent parasite genotypes observed in six animals sampled at different time-points over a 376 
nine-month period Uganda (Asiimwe et al., 2013). 377 
In the present study, a significantly higher number of genotypes were detected in grazed cattle 378 
compared to non-grazed ones (Fisher’s Exact Test, P < 0.001) which may indicate a lower level 379 
of exposure to challenge in cattle managed under non-grazing conditions with semi-closed 380 
and/or indoors management systems. Strikingly, in animals kept indoors, at farm AK, T. 381 
annulata was not detected (Supplementary Table S1). The influence of management systems 382 
on the prevalence of T. annulata has previously been highlighted (Calleja-Bueno et al., 2017) 383 
and variation in the prevalence of T. annulata infection among different management systems 384 
has been observed (Sayin et al., 2003) with a reduced rate of tick infestation and T. annulata 385 
infection reported in cattle being fed indoors compared to grazed cattle (Sayin et al., 2003). 386 
Vaccination status of cattle has previously been shown to influence MOI and a significantly 387 
higher number of T. annulata genotypes has been demonstrated in vaccinated animals than in 388 
non-vaccinated animals over a wide area (Weir et al., 2011). This raised the question of whether 389 
vaccinated and non-vaccinated animals co-grazing in a locality or farm show different MOI or 390 
not. To evaluate this, samples were collected from a cohort of non-vaccinated cattle co-grazing 391 
with the vaccinated ones during the peak of the disease season (at Day 105 post-vaccination) in a 392 
single farm (SC). Interestingly, and in contrast with previous data (Weir et al., 2011), no 393 
significant difference in MOI was observed among vaccinated and non-vaccinated cattle. It may 394 
be speculated that the earlier cross-sectional study was not as well-controlled as the present one 395 
and that the finding of a higher MOI in vaccinated animals was in fact due to some unidentified 396 
confounding factor, such as time of year when samples were taken, a parameter which we have 397 
shown here varies over the disease season. 398 
The importance of understanding the genetic composition of vaccine strains has been previously 399 
highlighted (Combrink et al., 2014; Di Giulio et al., 2009). Thus, it was decided to characterise 400 
the genetic composition of one commercial vaccine against tropical theileriosis, Teylovac, by 401 
deriving parasites clones and applying a multi-locus genotyping approach. The development and 402 
use of live, attenuated vaccines against tropical theileriosis has been well documented (Boulter 403 
and Hall, 1999; Darghouth et al., 1996; Shkap et al., 2007). Attenuation of T. annulata cell lines 404 
is achieved by long-term in vitro passage. This process results in the selection of avirulent 405 
parasite sub-populations and has been shown to be associated with a consistent reduction in 406 
parasite diversity, which may reduce to a single haploid genotype (Darghouth et al., 1996; Hall 407 
et al., 1999). In a previous study twelve years ago, the Teylovac vaccine strain was genotyped 408 
and this cell line was shown to possess a single allele at each locus, providing evidence of a 409 
single clonal genotype (Weir, 2006). In contrast, the present study demonstrates a low but 410 
detectable level of genetic polymorphism in a recent preparation of the vaccine. All 58 parasite 411 
clones tested possessed identical alleles at 20 of the 21 loci tested, resulting in a very low overall 412 
heterozygosity of 0.0114. Two closely-sized alleles (421 bp and 426 bp) were detected by 413 
marker MSC08 and a heterozygosity of 0.262 was calculated for this marker alone 414 
(Supplementary Table S5). Shifts in dominant populations have been previously reported 415 
during the attenuation and mass production of vaccine cell lines (Baravalle et al., 2012; Mazuz et 416 
al., 2012). However, in this case, the vaccine clones are identical at all other loci and the most 417 
parsimonious explanation it that this locus has experienced a relatively recent de novo mutation 418 
and that the original vaccine genotype was indeed a haploid clone. Microsatellite loci are known 419 
to be fast-evolving areas within eukaryotic genomes, which mutate by ‘strand slippage’ during 420 
the DNA replication process. The rate of such mutations is relatively high and has been 421 
estimated as between 10-6 and 10-2 per generation and instability is a common feature 422 
(Schlotterer, 2000). The vaccine strain was not cloned in the previous study and therefore a 423 
minor component beneath the detection threshold may have also been present. 424 
Alteration in transmission dynamics and population structure of the parasite population due to 425 
sustained use of live vaccines in endemic regions has previously been shown for the closely-426 
related parasite, T. parva (Di Giulio et al., 2009; Oura et al., 2004) and it has been proposed that 427 
such changes should be monitored for an extended time period at vaccination locations using a 428 
standardised protocol (Di Giulio et al., 2009). However, a low risk of spreading the vaccine 429 
strains into the field (Gubbels et al., 2000) was previously reported for T. annulata due to the 430 
complete attenuation in T. annulata schizont-infected cells. This contrasts with T. parva, for 431 
which attenuation of virulence is incomplete (Radley, 1975), and an infection and treatment 432 
method is used for immunisation. In T. annulata, following complete attenuation, the parasite 433 
loses its ability to differentiate into the piroplasm stage, and no piroplasms were reported in 434 
blood samples of cattle vaccinated with a T. annulata attenuated cell line in one trial (Boulter 435 
and Hall, 1999). However, other work has demonstrated a small number of piroplasms in calves 436 
inoculated with the Tunisian attenuated vaccine (Darghouth et al., 2006) and piroplasms have 437 
also reportedly been detected in animals at one month post-vaccination (Gubbels et al., 2000; 438 
Singh et al., 2001). Thus, the risk of introducing the vaccine strain into field populations remains 439 
a poorly quantified but undeniable risk and raises the question of whether repeated vaccination 440 
in an endemic region has a detectable impact on the field parasite population. In the present 441 
study, analysis of the entire dataset on marker-by-marker basis at each time-point post-442 
vaccination showed a significantly higher vaccine-allele frequency in vaccinated animals 45 443 
days post-immunisation (V1) than at the subsequent time-point (V2) and compared to the non-444 
vaccinated group (P < 0.01) (Fig 4A). The frequency of the vaccine-type alleles in vaccinated 445 
animals eventually fell in line with the frequency pre-vaccination and thus there was no evidence 446 
of an ongoing enrichment of the population. Additionally, the absence of the vaccine-type allele 447 
at the majority of loci in both V1 (Day 45) group and the non-vaccinated animals (Fig 4B) 448 
suggested only a subtle and transient impact on the genetic diversity of T. annulata population 449 
during the disease season. One explanation for this finding is that the Pendik vaccine strain has 450 
been attenuated for differentiation to the piroplasm and this stage is poorly represented in the 451 
red-cell population within vaccinated animals. This would represent a significant fitness cost to 452 
the vaccine genotype in the short-term, particularly in the face of competition with other 453 
genotypes continually infecting immunised cattle. Importantly, with the vaccine genotype not 454 
persisting in vaccinated animals at a detectable level in the transmissible piroplasm stage, the 455 
opportunity for ticks to become infected and for recombination and ongoing transmission to 456 
occur must be limited if not absent.  457 
Since a proportion of animals were vaccinated in previous years, we decided to test whether the 458 
vaccine genotype could be detected in any animal before this years’ vaccination. During the pre-459 
vaccination sampling period, multi-locus genotypes corresponding to the Teylovac strain were 460 
not detected in any of the cattle vaccinated during the previous year. This result provides further 461 
evidence that the vaccine genotype does not persist in the field population. It is encouraging that 462 
no direct evidence was found for the spread of the immunising genotype into the field population 463 
following repeated use of vaccination. However, it should be appreciated that while vaccination 464 
does not induce a carrier state characterised by detectable T. annulata in the circulation, the 465 
possibility that the immunising genotype is maintained in a sub-set of non-circulating leukocytes 466 
cannot be excluded. 467 
It is known that cell line induced immunity is not wholly protective against heterologous 468 
challenge (Pipano, 1981) and this has been linked to strain specificity of the cytotoxic T 469 
lymphocyte response (Machugh et al., 2008; Seitzer and Ahmed, 2008). This partial protection 470 
against heterologous genotypes has the potential to positively select for genotypes, which are not 471 
protected against, thereby altering the genetic composition of the parasite population. Analysis 472 
of parasite-population structure is therefore essential to provide evidence for the protection 473 
engendered by attenuated cell culture vaccines against heterologous field challenge (Gubbels et 474 
al., 2001). As such, long-term effectiveness of vaccines in endemic regions and the influence of 475 
vaccination on field parasite population dynamics remain unknown. In the present study, the 476 
effectiveness of the vaccine, Teylovac, was assessed over a course of a disease season. 477 
Considering the high-level of diversity in the local T. annulata population, it may be expected 478 
that the strain-specific immune response (Seitzer and Ahmed, 2008) induced in animals 479 
vaccinated with an essentially clonal cell line may be incapable of protecting cattle against 480 
challenge with heterologous genotypes of T. annulata. In this study, vaccine ‘breakthroughs’ 481 
(HO and SC) isolated from two vaccinated animals experiencing clinical tropical theileriosis was 482 
compared. An important consideration is whether cell line vaccine strains themselves can revert 483 
to virulence (Timms et al., 1990). The Teylovac genotype was not detected in either of the 484 
‘breakthrough’ isolates and clinical disease was attributed to field challenge. The clinical signs 485 
observed in SC ‘breakthrough’ isolate were more severe than that of HO isolate that showed 486 
lower heterozygosity and fewer distinct genotypes compare to SC. However, both isolates were 487 
genetically diverse and there was, therefore, no evidence of a clonal ‘breakthrough’ strain. 488 
Failure to protect may be related to factors such as pressure of infection and the immune 489 
competence of the individual cow response rather than on parasite genotype. The protection 490 
induced by attenuated cell lines depends on both antigenicity and the severity of the challenged 491 
infection (Darghouth, 2008) and previously, parasite diversity has been suggested to have a 492 
limited effect on the protective immunity induced by vaccination (Pipano and Shkap, 2000). 493 
While it is very possible that the genetic composition of the challenge strain does have a bearing 494 
on whether breakthrough is achieved, the genetic determinants of strain-specific immunity can 495 
not be resolved using a sparse multi-locus approach to genotyping, such as the one used in this 496 
study. 497 
5. Conclusion 498 
This study describes, for the first time, the dynamics of T. annulata infection and parasite 499 
genotypic diversity in animals vaccinated with a commercial cell line vaccine over the course of 500 
a disease season. The field parasite population was found to be highly diverse and an alteration 501 
in the major genotype and MOI was observed over the course of the season. Interestingly, 502 
vaccination status was shown not to affect within-host diversity in the middle of the disease 503 
season. From the results of this study, it can be concluded that there is no appreciable risk of 504 
introducing this vaccine genotype into the environment studied and there was only a subtle and 505 
transient effect on the genetic diversity of the T. annulata population post vaccination, with 506 
vaccine genotypes showing no evidence of persistence. However, the epidemiological situation 507 
may change from area to area with different parasite and tick populations, levels of challenge (Di 508 
Giulio et al., 2009) and vaccines used. These factors may influence the protectiveness of 509 
vaccination and it is therefore recommended that transmission dynamics and parasite population 510 
structure should be monitored in other areas using a standardised protocol (Di Giulio et al., 511 
2009). These results and those of others clearly indicate the necessity of evaluating parameters 512 
related to host, vector and parasite including genotypic diversity of the parasite within the cattle 513 
and tick, intensity of tick burden on cattle, infection rates of the ticks and genotypic composition 514 
of the vaccine (Auburn et al., 2012; Elisa et al., 2015) before the deployment of live, vaccine 515 
based control strategies. Using genetically and/or immunologically characterised region-specific 516 
vaccines may be suitable in regions where presumed vaccine breakthroughs are likely to happen 517 
(Di Giulio et al., 2009). As highlighted previously (Darghouth et al., 2006), there is a need for 518 
development of new control strategies such as the identification of conserved ‘hidden’ parasite 519 
vaccine antigens that are able to block transmission of parasite ticks, circumventing problems 520 
associated with highly diverse field populations. 521 
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FIGURE LEGENDS 705 
Figure 1. A diagram showing the experimental work-flow of this study. 706 
Figure 2. Principle co-ordinate (PCoA) analysis of multi-locus genotypes detected on six farms 707 
in Akçaova district. The two principal axes generated by this analysis are presented, 708 
demonstrating a diverse range of parasite genotypes identified in the vaccinated cattle and a 709 
degree of genetic isolation between T. annulata genotypes at a local level. Data points 710 
representing different vaccinated animals are colour-coded to indicate their farms and the MLGs 711 
from the three positive animals at all five sampling time-points were identified and their 712 
centroids defined. The proportion of the variation in the dataset explained by each axis is 713 
indicated in parentheses. 714 
Figure 3. Multiplicity of infection over the disease season in grazing animals (A) and in 715 
longitudinally sampled individual grazed cattle at different farms (B). These charts were 716 
generated for each isolate by calculating the average number of alleles present per locus. 717 
Figure 4. Enrichment for Teylovac alleles to determine the presence of vaccine genotypes as a 718 
minor component within the complex mixture of field genotypes. (A) The frequency of 719 
Teylovac-type alleles on a marker-by-marker basis at each time-point post-vaccination. A 720 
difference in vaccine-allele frequency was detected between the groups (One-way ANOVA, 721 
P < 0.001). Post hoc analysis using Tukey HSD, Scheffé and Bonferroni and Holm tests indicate 722 
that the V1 group is higher than both the V2 (P < 0.01) and NV (P < 0.01) group.  (B) 723 
Comparison of the frequency of vaccine alleles at each marker at the Day 45 time-point in 724 
vaccinated vs non-vaccinated cattle. These two histograms were directly generated from the 725 
multi-locus genotype data. 726 
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